$PVCT
PROVECTUS BIOPHARMACEUTICALS, INC.

2013 Q3 Form 10-Q Financial Statement

#000119312513436620 Filed on November 12, 2013

View on sec.gov

Income Statement

Concept 2013 Q3 2012 Q4 2012 Q3
Revenue
YoY Change
Cost Of Revenue $0.00 $0.00
YoY Change
Gross Profit $0.00 $0.00
YoY Change
Gross Profit Margin
Selling, General & Admin $2.190M $1.430M $2.300M
YoY Change -4.78% -40.17% -40.41%
% of Gross Profit
Research & Development $1.297M $650.0K $1.130M
YoY Change 14.76% -64.67% -67.15%
% of Gross Profit
Depreciation & Amortization $160.0K $180.0K $160.0K
YoY Change 0.0% 5.88% -5.88%
% of Gross Profit
Operating Expenses $1.297M $2.250M $1.130M
YoY Change 14.76% -48.86% -84.87%
Operating Profit -$3.650M -$2.253M -$3.594M
YoY Change 1.56% -48.8% -51.89%
Interest Expense -$900.0K $330.0K $1.250M
YoY Change -172.0% -65.26% 21.36%
% of Operating Profit
Other Income/Expense, Net -$903.0K $332.0K $1.247M
YoY Change -172.41%
Pretax Income -$4.550M -$1.920M -$2.350M
YoY Change 93.62% -44.35% -63.51%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$4.553M -$1.921M -$2.347M
YoY Change 93.99% -44.32% -63.56%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$34.58K -$16.59K -$20.77K
COMMON SHARES
Basic Shares Outstanding 140.0M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2013 Q3 2012 Q4 2012 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $8.250M $1.220M $1.840M
YoY Change 348.37% -84.18% -82.98%
Cash & Equivalents $8.254M $1.222M $1.842M
Short-Term Investments
Other Short-Term Assets $50.00K $20.00K
YoY Change 150.0% -50.0%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $8.299M $1.222M $1.860M
YoY Change 346.18% -84.15% -82.87%
LONG-TERM ASSETS
Property, Plant & Equipment $31.83K $29.83K $30.00K
YoY Change 6.1% 49.15% 50.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $27.00K $27.00K $30.00K
YoY Change -10.0% -10.0% 0.0%
Total Long-Term Assets $4.481M $4.983M $5.150M
YoY Change -12.98% -11.65% -11.36%
TOTAL ASSETS
Total Short-Term Assets $8.299M $1.222M $1.860M
Total Long-Term Assets $4.481M $4.983M $5.150M
Total Assets $12.78M $6.204M $7.010M
YoY Change 82.32% -53.52% -57.95%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $200.0K $243.4K $280.0K
YoY Change -28.57% 143.44% 86.67%
Accrued Expenses $340.0K $270.0K $1.670M
YoY Change -79.64% 68.75% 391.18%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $542.5K $511.4K $1.960M
YoY Change -72.32% 96.7% 300.0%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $3.510M $1.300M $1.630M
YoY Change 115.34% -57.65% -59.35%
Total Long-Term Liabilities $3.510M $1.300M $1.630M
YoY Change 115.34% -57.65% -59.35%
TOTAL LIABILITIES
Total Short-Term Liabilities $542.5K $511.4K $1.960M
Total Long-Term Liabilities $3.510M $1.300M $1.630M
Total Liabilities $4.057M $1.811M $3.590M
YoY Change 13.01% -45.62% -20.22%
SHAREHOLDERS EQUITY
Retained Earnings -$129.5M -$118.4M
YoY Change
Common Stock $140.0K $118.4K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $8.723M $4.393M $3.420M
YoY Change
Total Liabilities & Shareholders Equity $12.78M $6.204M $7.010M
YoY Change 82.32% -53.52% -57.95%

Cashflow Statement

Concept 2013 Q3 2012 Q4 2012 Q3
OPERATING ACTIVITIES
Net Income -$4.553M -$1.921M -$2.347M
YoY Change 93.99% -44.32% -63.56%
Depreciation, Depletion And Amortization $160.0K $180.0K $160.0K
YoY Change 0.0% 5.88% -5.88%
Cash From Operating Activities -$2.760M -$3.330M -$2.230M
YoY Change 23.77% -15.48% -40.85%
INVESTING ACTIVITIES
Capital Expenditures -$10.00K $0.00 $0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00
YoY Change
Cash From Investing Activities -$10.00K $0.00 $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 6.390M 2.710M 0.000
YoY Change 222.62% -100.0%
NET CHANGE
Cash From Operating Activities -2.760M -3.330M -2.230M
Cash From Investing Activities -10.00K 0.000 0.000
Cash From Financing Activities 6.390M 2.710M 0.000
Net Change In Cash 3.620M -620.0K -2.230M
YoY Change -262.33% -80.0% -37.71%
FREE CASH FLOW
Cash From Operating Activities -$2.760M -$3.330M -$2.230M
Capital Expenditures -$10.00K $0.00 $0.00
Free Cash Flow -$2.750M -$3.330M -$2.230M
YoY Change 23.32% -15.48% -40.85%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2002Q1 us-gaap Stockholders Equity
StockholdersEquity
CY2013Q1 pvct Securities Purchase Agreement Price Per Unit
SecuritiesPurchaseAgreementPricePerUnit
0.75
CY2002Q2 us-gaap Stockholders Equity
StockholdersEquity
802
CY2013Q3 pvct Purchase Agreement Of Share Issuance Maximum Amount
PurchaseAgreementOfShareIssuanceMaximumAmount
30000000
CY2013Q3 pvct Purchase Agreement Of Share Issuance Maximum Number Of Shares To Be Issued
PurchaseAgreementOfShareIssuanceMaximumNumberOfSharesToBeIssued
100000 shares
CY2013Q3 pvct Purchase Agreement Of Share Issuance Maximum Number Of Shares To Be Issued In Single Regular Purchase
PurchaseAgreementOfShareIssuanceMaximumNumberOfSharesToBeIssuedInSingleRegularPurchase
250000 shares
CY2013Q3 pvct Purchase Agreement Of Share Issuance Price Per Share
PurchaseAgreementOfShareIssuancePricePerShare
0.75
CY2012Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1842118
CY2013Q1 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
7277264 shares
CY2013Q1 pvct Class Of Warrants Or Right Exercise Price Of Warrants Or Rights
ClassOfWarrantsOrRightExercisePriceOfWarrantsOrRights
1.00
CY2013Q1 pvct Common Stock Unit Beneficial Conversion Amount
CommonStockUnitBeneficialConversionAmount
1025950
CY2013Q1 pvct Securities Purchase Agreement Price Per Unit
SecuritiesPurchaseAgreementPricePerUnit
0.75
CY2013Q1 pvct Common Stock Unit Fair Value Of Warrants Recorded On Issuance
CommonStockUnitFairValueOfWarrantsRecordedOnIssuance
1297950
CY2013Q2 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
5283003 shares
CY2013Q2 pvct Class Of Warrants Or Right Exercise Price Of Warrants Or Rights
ClassOfWarrantsOrRightExercisePriceOfWarrantsOrRights
1.00
CY2013Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
139974331 shares
CY2013Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
139974331 shares
CY2013Q3 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
9226077 shares
CY2013Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
139974331 shares
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
shares
CY2013Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
25000000 shares
CY2013Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2013Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
CY2013Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2013Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2013Q3 us-gaap Preferred Stock Value
PreferredStockValue
3705
CY2013Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
427615
CY2013Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
180001
CY2013Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
138032870
CY2013Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
61282
CY2013Q3 us-gaap Liabilities Current
LiabilitiesCurrent
542467
CY2013Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
98720
CY2013Q3 us-gaap Stockholders Equity
StockholdersEquity
8723223
CY2013Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-129453326
CY2013Q3 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
202464
CY2013Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
7292837
CY2013Q3 us-gaap Common Stock Value
CommonStockValue
139974
CY2013Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
12780312
CY2013Q3 us-gaap Liabilities
Liabilities
4057089
CY2013Q3 us-gaap Assets Current
AssetsCurrent
8298875
CY2013Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
27000
CY2013Q3 us-gaap Assets
Assets
12780312
CY2013Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
8253591
CY2013Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
4422608
CY2013Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
45284
CY2013Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
0
CY2013Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
31829
CY2013Q3 pvct Class Of Warrants Or Right Exercise Price Of Warrants Or Rights
ClassOfWarrantsOrRightExercisePriceOfWarrantsOrRights
1.00
CY2013Q3 pvct Warrant Liability
WarrantLiability
3514622
CY2013Q3 pvct Convertible Preferred Stock Par Value Per Share Securities Purchase Agreement
ConvertiblePreferredStockParValuePerShareSecuritiesPurchaseAgreement
0.001
CY2013Q3 pvct Number Of Non Employee To Whom Consulting Services Paid
NumberOfNonEmployeeToWhomConsultingServicesPaid
1 NonEmployee
CY2002Q4 us-gaap Stockholders Equity
StockholdersEquity
11723580
CY2003Q4 us-gaap Stockholders Equity
StockholdersEquity
10251052
CY2004Q4 us-gaap Stockholders Equity
StockholdersEquity
9161701
CY2005Q4 us-gaap Stockholders Equity
StockholdersEquity
14387141
CY2006Q4 us-gaap Stockholders Equity
StockholdersEquity
15522400
CY2007Q4 us-gaap Stockholders Equity
StockholdersEquity
14831510
CY2008Q4 us-gaap Stockholders Equity
StockholdersEquity
10055536
CY2009Q4 us-gaap Stockholders Equity
StockholdersEquity
9406510
CY2010Q4 us-gaap Stockholders Equity
StockholdersEquity
10699573
CY2011Q4 us-gaap Stockholders Equity
StockholdersEquity
10019740
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
7705773
CY2012Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
118427925 shares
CY2012Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
118427925 shares
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
shares
CY2012Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
25000000 shares
CY2012Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2012Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
CY2012Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2012Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2012Q4 us-gaap Preferred Stock Value
PreferredStockValue
2478
CY2012Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
422965
CY2012Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
206706
CY2012Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
122625654
CY2012Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
61283
CY2012Q4 us-gaap Liabilities Current
LiabilitiesCurrent
511424
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
4393484
CY2012Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-118353076
CY2012Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
243435
CY2012Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
6789497
CY2012Q4 us-gaap Common Stock Value
CommonStockValue
118428
CY2012Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
6204478
CY2012Q4 us-gaap Liabilities
Liabilities
1810994
CY2012Q4 us-gaap Assets Current
AssetsCurrent
1221701
CY2012Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
27000
CY2012Q4 us-gaap Assets
Assets
6204478
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1221701
CY2012Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
4925948
CY2012Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
29829
CY2012Q4 pvct Warrant Liability
WarrantLiability
1299570
CY2013Q3 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
250000 shares
CY2013Q3 pvct Purchase Agreement Of Share Issuance Period Of Shares To Be Issued
PurchaseAgreementOfShareIssuancePeriodOfSharesToBeIssued
P30M
CY2013Q3 pvct Commitment Fee
CommitmentFee
162500
us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
126587
us-gaap Net Income Loss
NetIncomeLoss
-5749937
us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
48000
pvct Stock And Warrant Issued During Period Value
StockAndWarrantIssuedDuringPeriodValue
27000
pvct Stock Issued For Acquisition
StockIssuedForAcquisition
12226320
pvct Warrant Exercised During Period Value
WarrantExercisedDuringPeriodValue
453
pvct Stock Issued During Period In Reverse Merger Value
StockIssuedDuringPeriodInReverseMergerValue
-3645
pvct Stock Issued During Period For Services Value
StockIssuedDuringPeriodForServicesValue
5144000
dei Entity Registrant Name
EntityRegistrantName
PROVECTUS PHARMACEUTICALS INC
dei Amendment Flag
AmendmentFlag
false
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2013
dei Document Type
DocumentType
10-Q
dei Document Period End Date
DocumentPeriodEndDate
2013-09-30
dei Entity Central Index Key
EntityCentralIndexKey
0000315545
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
us-gaap Stock Issued During Period Shares Issued For Cash
StockIssuedDuringPeriodSharesIssuedForCash
3583333 shares
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-7707571
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
250000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
shares
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
us-gaap Gross Profit
GrossProfit
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-12288898
us-gaap Investment Income Interest
InvestmentIncomeInterest
576
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
us-gaap Operating Income Loss
OperatingIncomeLoss
-10183724
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
45284
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
us-gaap Net Income Loss
NetIncomeLoss
-11100250
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
-29063
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
us-gaap Sales Revenue Net
SalesRevenueNet
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
6650
us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
48000
us-gaap Stock Option Plan Expense
StockOptionPlanExpense
142310
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6864865
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
14746111
us-gaap Dividends Preferred Stock
DividendsPreferredStock
1188648
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
7031890
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
72014
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-6650
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2815519
us-gaap Proceeds From Divestiture Of Interest In Consolidated Subsidiaries
ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
503340
us-gaap Dividends Preferred Stock Cash
DividendsPreferredStockCash
29063
us-gaap Depreciation
Depreciation
4650
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
142310
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-40971
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
pvct Gross Proceeds From Sales Of Common Stock And Warrants
GrossProceedsFromSalesOfCommonStockAndWarrants
2687500
pvct Net Proceeds From Loans From Stockholder
NetProceedsFromLoansFromStockholder
pvct Premium Paid On Extinguishments Of Debt
PremiumPaidOnExtinguishmentsOfDebt
pvct Gain Loss On Change In Fair Value Of Warrant Liability
GainLossOnChangeInFairValueOfWarrantLiability
-917102
pvct Compensation Through Issuance Of Stock
CompensationThroughIssuanceOfStock
pvct Stock Issued During Period Warrants And Stock Options Exercised Value
StockIssuedDuringPeriodWarrantsAndStockOptionsExercisedValue
21000
pvct Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.57
pvct Warrant Issued During Period For Services Value
WarrantIssuedDuringPeriodForServicesValue
1527518
pvct Convertible Interest
ConvertibleInterest
pvct Gain Loss On Fair Value Of Warrant Liability
GainLossOnFairValueOfWarrantLiability
-917102
pvct Period Of Warrants To Purchase Common Stock
PeriodOfWarrantsToPurchaseCommonStock
P5Y
pvct Cash Paid For Deferred Loan Costs
CashPaidForDeferredLoanCosts
pvct Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsForfeituresWeightedAverageGrantDateFairValue
pvct Proceeds From Exercises Of Warrants And Stock Options
ProceedsFromExercisesOfWarrantsAndStockOptions
21000
pvct Net Proceeds From Sales Of Common Stock And Warrants
NetProceedsFromSalesOfCommonStockAndWarrants
12204174
pvct Percentage Of Aggregate Shares Called By Warrant
PercentageOfAggregateSharesCalledByWarrant
0.10 pure
pvct Issuance Of Stock For Services
IssuanceOfStockForServices
312000
pvct Issuance Of Warrants For Services
IssuanceOfWarrantsForServices
-1527518
pvct Net Proceeds From Sales Of Preferred Stock And Warrants
NetProceedsFromSalesOfPreferredStockAndWarrants
2550000
pvct Amortization Of Commitment Fee
AmortizationOfCommitmentFee
pvct Preferred Stock Issued During Period Pursuant To Regulation Of Value
PreferredStockIssuedDuringPeriodPursuantToRegulationOfValue
1252050
pvct Issuance Of Common Stock And Warrants Pursuant To Regulation D Value
IssuanceOfCommonStockAndWarrantsPursuantToRegulationDValue
12204174
pvct Stock Issued During Period For Services Value
StockIssuedDuringPeriodForServicesValue
149500
pvct Loss On Exercise Of Warrants
LossOnExerciseOfWarrants
pvct Accretion Of United States Treasury Bills
AccretionOfUnitedStatesTreasuryBills
pvct Basic And Diluted Loss Per Common Share
BasicAndDilutedLossPerCommonShare
-0.10
pvct Amortization Of Prepaid Consultant Expense
AmortizationOfPrepaidConsultantExpense
pvct Medical Device Revenue
MedicalDeviceRevenue
pvct Issuance Of Warrants For Contractual Obligations
IssuanceOfWarrantsForContractualObligations
pvct Common Stock Issued Under Recapitalization Transactions
CommonStockIssuedUnderRecapitalizationTransactions
6680000 shares
pvct Beneficial Conversion Of Convertible Interest
BeneficialConversionOfConvertibleInterest
pvct Purchase Price Of Common Stock With Warrants
PurchasePriceOfCommonStockWithWarrants
0.75
pvct Weighted Average Number Of Common Shares Outstanding Basic And Diluted
WeightedAverageNumberOfCommonSharesOutstandingBasicAndDiluted
126503388 shares
pvct Adjustments To Additional Paid In Capital Employee Compensation From Stock Options Value
AdjustmentsToAdditionalPaidInCapitalEmployeeCompensationFromStockOptionsValue
142310
pvct Share Based Compensation Arrangement By Share Based Payment Award Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedInPeriod
250000 shares
pvct Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsVestedInPeriodWeightedAverageGrantDateFairValue
0.57
pvct Cash Paid For Preferred Dividend
CashPaidForPreferredDividend
29063
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-7925566
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-10792991
us-gaap Investment Income Interest
InvestmentIncomeInterest
1325
us-gaap Operating Income Loss
OperatingIncomeLoss
-12084505
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
16284
us-gaap Net Income Loss
NetIncomeLoss
-10647282
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
15885
us-gaap Stock Option Plan Expense
StockOptionPlanExpense
183028
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7228225
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2077796
us-gaap Dividends Preferred Stock
DividendsPreferredStock
145709
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-5863655
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1512859
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-15885
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4352940
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
503340
us-gaap Depreciation
Depreciation
4579
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
183028
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
179513
pvct Gain Loss On Change In Fair Value Of Warrant Liability
GainLossOnChangeInFairValueOfWarrantLiability
1435898
pvct Gain Loss On Fair Value Of Warrant Liability
GainLossOnFairValueOfWarrantLiability
1435898
pvct Net Proceeds From Sales Of Common Stock And Warrants
NetProceedsFromSalesOfCommonStockAndWarrants
2077796
pvct Issuance Of Stock For Services
IssuanceOfStockForServices
409250
pvct Issuance Of Warrants For Services
IssuanceOfWarrantsForServices
-1381329
pvct Basic And Diluted Loss Per Common Share
BasicAndDilutedLossPerCommonShare
-0.10
pvct Weighted Average Number Of Common Shares Outstanding Basic And Diluted
WeightedAverageNumberOfCommonSharesOutstandingBasicAndDiluted
112073836 shares
CY2013Q1 pvct Units Issued During Period Value Securities Purchase Agreement
UnitsIssuedDuringPeriodValueSecuritiesPurchaseAgreement
2550000
CY2013Q1 us-gaap Dividends Preferred Stock Stock
DividendsPreferredStockStock
61022
CY2013Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares
25000 shares
CY2003 us-gaap Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
601000
CY2003 us-gaap Net Income Loss
NetIncomeLoss
-3155313
CY2003 pvct Warrant Issued During Period For Services Value
WarrantIssuedDuringPeriodForServicesValue
145479
CY2003 pvct Adjustments To Additional Paid In Capital Stock To Be Issued For Services Value
AdjustmentsToAdditionalPaidInCapitalStockToBeIssuedForServicesValue
281500
CY2003 pvct Stock Issued During Period For Services Value
StockIssuedDuringPeriodForServicesValue
239800
CY2003 pvct Stock Issued During Period Pursuant To Regulation S Value
StockIssuedDuringPeriodPursuantToRegulationSValue
380347
CY2003 pvct Adjustments To Additional Paid In Capital Employee Compensation From Stock Options Value
AdjustmentsToAdditionalPaidInCapitalEmployeeCompensationFromStockOptionsValue
34659
CY2005 us-gaap Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
1633176
CY2005 us-gaap Net Income Loss
NetIncomeLoss
-11763853
CY2005 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
3049362
CY2005 pvct Stock Issued During Period For Interest Payable Value
StockIssuedDuringPeriodForInterestPayableValue
196031
CY2005 pvct Adjustments To Additional Paid In Capital Issuance Of Convertible Debt With Warrants Value
AdjustmentsToAdditionalPaidInCapitalIssuanceOfConvertibleDebtWithWarrantsValue
1574900
CY2005 pvct Stock Issued During Period Pursuant To Regulation D Value
StockIssuedDuringPeriodPursuantToRegulationDValue
6513176
CY2005 pvct Stock Issued During Period Warrants And Stock Options Exercised Value
StockIssuedDuringPeriodWarrantsAndStockOptionsExercisedValue
1439795
CY2005 pvct Warrant Issued During Period For Services Value
WarrantIssuedDuringPeriodForServicesValue
1534405
CY2005 pvct Adjustments To Additional Paid In Capital Issuance Of Warrants For Contractual Obligations Value
AdjustmentsToAdditionalPaidInCapitalIssuanceOfWarrantsForContractualObligationsValue
985010
CY2005 pvct Adjustments To Additional Paid In Capital Beneficial Conversion Related To Interest Expense Value
AdjustmentsToAdditionalPaidInCapitalBeneficialConversionRelatedToInterestExpenseValue
39529
CY2005 pvct Stock Issued During Period For Services Value
StockIssuedDuringPeriodForServicesValue
152285
CY2005 pvct Adjustments To Additional Paid In Capital Repurchase Of Beneficial Conversion Feature Value
AdjustmentsToAdditionalPaidInCapitalRepurchaseOfBeneficialConversionFeatureValue
144128
CY2005 pvct Adjustments To Additional Paid In Capital Employee Compensation From Stock Options Value
AdjustmentsToAdditionalPaidInCapitalEmployeeCompensationFromStockOptionsValue
15752
CY2006 us-gaap Net Income Loss
NetIncomeLoss
-8870579
CY2006 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
1576336
CY2006 pvct Stock Issued During Period For Interest Payable Value
StockIssuedDuringPeriodForInterestPayableValue
183596
CY2006 pvct Stock Issued During Period Pursuant To Regulation D Value
StockIssuedDuringPeriodPursuantToRegulationDValue
4130421
CY2006 pvct Stock Issued During Period Warrants And Stock Options Exercised Value
StockIssuedDuringPeriodWarrantsAndStockOptionsExercisedValue
1189816
CY2006 pvct Warrant Issued During Period For Services Value
WarrantIssuedDuringPeriodForServicesValue
370023
CY2006 pvct Adjustments To Additional Paid In Capital Beneficial Conversion Related To Interest Expense Value
AdjustmentsToAdditionalPaidInCapitalBeneficialConversionRelatedToInterestExpenseValue
16447
CY2006 pvct Stock Issued During Period For Services Value
StockIssuedDuringPeriodForServicesValue
676743
CY2006 pvct Adjustments To Additional Paid In Capital Employee Compensation From Stock Options Value
AdjustmentsToAdditionalPaidInCapitalEmployeeCompensationFromStockOptionsValue
1862456
CY2007 us-gaap Net Income Loss
NetIncomeLoss
-10005631
CY2007 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
367500
CY2007 pvct Stock Issued During Period For Interest Payable Value
StockIssuedDuringPeriodForInterestPayableValue
1258
CY2007 pvct Stock Issued During Period Pursuant To Regulation D Value
StockIssuedDuringPeriodPursuantToRegulationDValue
1848138
CY2007 pvct Stock Issued During Period Warrants And Stock Options Exercised Value
StockIssuedDuringPeriodWarrantsAndStockOptionsExercisedValue
3985641
CY2007 pvct Warrant Issued During Period For Services Value
WarrantIssuedDuringPeriodForServicesValue
472635
CY2007 pvct Stock Issued During Period For Services Value
StockIssuedDuringPeriodForServicesValue
298950
CY2010 pvct Stock Issued During Period Pursuant To Regulation S Value
StockIssuedDuringPeriodPursuantToRegulationSValue
419250
CY2010 pvct Adjustments To Additional Paid In Capital Employee Compensation From Stock Options Value
AdjustmentsToAdditionalPaidInCapitalEmployeeCompensationFromStockOptionsValue
3759650
CY2011 us-gaap Net Income Loss
NetIncomeLoss
-19434699
CY2011 pvct Adjustment To Additional Paid In Capital Sale Of Non Controlling Interest And Warrants
AdjustmentToAdditionalPaidInCapitalSaleOfNonControllingInterestAndWarrants
443500
CY2011 pvct Stock Issued During Period Warrants And Stock Options Exercised Value
StockIssuedDuringPeriodWarrantsAndStockOptionsExercisedValue
6623311
CY2011 pvct Warrant Issued During Period For Services Value
WarrantIssuedDuringPeriodForServicesValue
945116
CY2007 pvct Adjustments To Additional Paid In Capital Employee Compensation From Stock Options Value
AdjustmentsToAdditionalPaidInCapitalEmployeeCompensationFromStockOptionsValue
2340619
CY2009 us-gaap Net Income Loss
NetIncomeLoss
-12322314
CY2009 pvct Stock Issued During Period Pursuant To Regulation D Value
StockIssuedDuringPeriodPursuantToRegulationDValue
6518688
CY2009 pvct Stock Issued During Period Warrants And Stock Options Exercised Value
StockIssuedDuringPeriodWarrantsAndStockOptionsExercisedValue
2524453
CY2009 pvct Warrant Issued During Period For Services Value
WarrantIssuedDuringPeriodForServicesValue
1064210
CY2009 pvct Stock Issued During Period For Services Value
StockIssuedDuringPeriodForServicesValue
695000
CY2009 pvct Adjustments To Additional Paid In Capital Employee Compensation From Stock Options Value
AdjustmentsToAdditionalPaidInCapitalEmployeeCompensationFromStockOptionsValue
870937
CY2010 us-gaap Net Income Loss
NetIncomeLoss
-18552102
CY2010 pvct Stock Issued During Period Warrants And Stock Options Exercised Value
StockIssuedDuringPeriodWarrantsAndStockOptionsExercisedValue
3103680
CY2010 pvct Warrant Issued During Period For Services Value
WarrantIssuedDuringPeriodForServicesValue
1141593
CY2010 pvct Preferred Stock Issued During Period Pursuant To Regulation Of Value
PreferredStockIssuedDuringPeriodPursuantToRegulationOfValue
4217390
CY2010 pvct Issuance Of Common Stock And Warrants Pursuant To Regulation D Value
IssuanceOfCommonStockAndWarrantsPursuantToRegulationDValue
6346989
CY2010 pvct Stock Issued During Period For Services Value
StockIssuedDuringPeriodForServicesValue
856613
CY2011 pvct Issuance Of Common Stock And Warrants Pursuant To Regulation D Value
IssuanceOfCommonStockAndWarrantsPursuantToRegulationDValue
7041239
CY2011 pvct Stock Issued During Period For Services Value
StockIssuedDuringPeriodForServicesValue
332750
CY2011 pvct Adjustments To Additional Paid In Capital Employee Compensation From Stock Options Value
AdjustmentsToAdditionalPaidInCapitalEmployeeCompensationFromStockOptionsValue
3368950
CY2004 us-gaap Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
360256
CY2004 us-gaap Net Income Loss
NetIncomeLoss
-4344525
CY2004 pvct Adjustments To Additional Paid In Capital Issuance Of Convertible Debt With Warrants Value
AdjustmentsToAdditionalPaidInCapitalIssuanceOfConvertibleDebtWithWarrantsValue
105250
CY2004 pvct Stock Issued During Period Pursuant To Regulation D Value
StockIssuedDuringPeriodPursuantToRegulationDValue
1288861
CY2004 pvct Warrant Exercised During Period Value
WarrantExercisedDuringPeriodValue
5000
CY2004 pvct Warrant Issued During Period For Services Value
WarrantIssuedDuringPeriodForServicesValue
495480
CY2004 pvct Stock Issued During Period For Services Value
StockIssuedDuringPeriodForServicesValue
449923
CY2004 pvct Stock Issued During Period Pursuant To Regulation S Value
StockIssuedDuringPeriodPursuantToRegulationSValue
793137
CY2004 pvct Adjustments To Additional Paid In Capital Repurchase Of Beneficial Conversion Feature Value
AdjustmentsToAdditionalPaidInCapitalRepurchaseOfBeneficialConversionFeatureValue
258345
CY2004 pvct Adjustments To Additional Paid In Capital Employee Compensation From Stock Options Value
AdjustmentsToAdditionalPaidInCapitalEmployeeCompensationFromStockOptionsValue
15612
CY2008 us-gaap Net Income Loss
NetIncomeLoss
-10269571
CY2008 pvct Stock Issued During Period Warrants And Stock Options Exercised Value
StockIssuedDuringPeriodWarrantsAndStockOptionsExercisedValue
2639711
CY2008 pvct Warrant Issued During Period For Services Value
WarrantIssuedDuringPeriodForServicesValue
517820
CY2008 pvct Stock Issued During Period For Services Value
StockIssuedDuringPeriodForServicesValue
390000
CY2008 pvct Adjustments To Additional Paid In Capital Employee Compensation From Stock Options Value
AdjustmentsToAdditionalPaidInCapitalEmployeeCompensationFromStockOptionsValue
1946066
CY2012 us-gaap Net Income Loss
NetIncomeLoss
-12568354
CY2012 pvct Warrant Issued During Period For Services Value
WarrantIssuedDuringPeriodForServicesValue
1512026
CY2012 pvct Issuance Of Common Stock And Warrants Pursuant To Regulation D Value
IssuanceOfCommonStockAndWarrantsPursuantToRegulationDValue
4790544
CY2012 pvct Stock Issued During Period For Services Value
StockIssuedDuringPeriodForServicesValue
456500
CY2012 pvct Adjustments To Additional Paid In Capital Employee Compensation From Stock Options Value
AdjustmentsToAdditionalPaidInCapitalEmployeeCompensationFromStockOptionsValue
183028
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-83722191
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-8098004
us-gaap Gross Profit
GrossProfit
24541
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
55075
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
25648
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-141480036
us-gaap Investment Income Interest
InvestmentIncomeInterest
653793
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-825867
us-gaap Operating Income Loss
OperatingIncomeLoss
-126233422
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
45284
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
36637186
us-gaap Net Income Loss
NetIncomeLoss
-129453326
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
48000
us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
2385959
us-gaap Sales Revenue Net
SalesRevenueNet
39757
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
96570
us-gaap Stock Option Plan Expense
StockOptionPlanExpense
14540039
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
73050754
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
91518982
us-gaap Dividends Preferred Stock
DividendsPreferredStock
12026710
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
15216
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
37010481
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
8253591
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
489633
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
180075
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
456800
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
45914372
us-gaap Proceeds From Divestiture Of Interest In Consolidated Subsidiaries
ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries
443500
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
2261584
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
7292837
us-gaap Depreciation
Depreciation
450616
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
3845721
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
198819
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
6706795
pvct Net Proceeds From Loans From Stockholder
NetProceedsFromLoansFromStockholder
174000
pvct Premium Paid On Extinguishments Of Debt
PremiumPaidOnExtinguishmentsOfDebt
170519
pvct Gain Loss On Change In Fair Value Of Warrant Liability
GainLossOnChangeInFairValueOfWarrantLiability
4995099
pvct Compensation Through Issuance Of Stock
CompensationThroughIssuanceOfStock
-932000
pvct Convertible Interest
ConvertibleInterest
389950
pvct Gain Loss On Fair Value Of Warrant Liability
GainLossOnFairValueOfWarrantLiability
4995099
pvct Cash Paid For Deferred Loan Costs
CashPaidForDeferredLoanCosts
747612
pvct Proceeds From Exercises Of Warrants And Stock Options
ProceedsFromExercisesOfWarrantsAndStockOptions
21099014
pvct Net Proceeds From Sales Of Common Stock And Warrants
NetProceedsFromSalesOfCommonStockAndWarrants
55018695
pvct Issuance Of Stock For Services
IssuanceOfStockForServices
9365511
pvct Issuance Of Warrants For Services
IssuanceOfWarrantsForServices
-7724087
pvct Net Proceeds From Sales Of Preferred Stock And Warrants
NetProceedsFromSalesOfPreferredStockAndWarrants
11458131
pvct Amortization Of Commitment Fee
AmortizationOfCommitmentFee
310866
pvct Loss On Exercise Of Warrants
LossOnExerciseOfWarrants
236146
pvct Accretion Of United States Treasury Bills
AccretionOfUnitedStatesTreasuryBills
373295
pvct Amortization Of Prepaid Consultant Expense
AmortizationOfPrepaidConsultantExpense
1295226
pvct Medical Device Revenue
MedicalDeviceRevenue
14109
pvct Issuance Of Warrants For Contractual Obligations
IssuanceOfWarrantsForContractualObligations
-985010
pvct Beneficial Conversion Of Convertible Interest
BeneficialConversionOfConvertibleInterest
55976
pvct Cash Paid For Preferred Dividend
CashPaidForPreferredDividend
29063
CY2013Q1 us-gaap Stock Issued During Period Shares Issued For Cash
StockIssuedDuringPeriodSharesIssuedForCash
5394013 shares
CY2013Q1 us-gaap Share Based Goods And Nonemployee Services Transaction Quantity Of Securities Issued
ShareBasedGoodsAndNonemployeeServicesTransactionQuantityOfSecuritiesIssued
75000 shares
CY2013Q1 pvct Consulting Costs Relates To Warrant Issued
ConsultingCostsRelatesToWarrantIssued
409640
CY2013Q1 pvct Gross Proceeds From Sales Of Common Stock And Warrants
GrossProceedsFromSalesOfCommonStockAndWarrants
4045510
CY2013Q1 pvct Period Of Warrants To Purchase Common Stock
PeriodOfWarrantsToPurchaseCommonStock
P5Y
CY2013Q1 pvct Share Based Goods And Nonemployee Services Transaction Quantity Of Warrants Forfeited
ShareBasedGoodsAndNonemployeeServicesTransactionQuantityOfWarrantsForfeited
859833 shares
CY2013Q1 pvct Gain Loss On Revaluation Of Warrants Liability
GainLossOnRevaluationOfWarrantsLiability
311062
CY2013Q1 pvct Percentage Of Aggregate Shares Called By Warrant
PercentageOfAggregateSharesCalledByWarrant
0.10 pure
CY2013Q1 pvct Share Based Goods And Nonemployee Services Transaction Quantity Of Warrants Issued
ShareBasedGoodsAndNonemployeeServicesTransactionQuantityOfWarrantsIssued
1924973 shares
CY2012Q1 us-gaap Share Based Goods And Nonemployee Services Transaction Quantity Of Securities Issued
ShareBasedGoodsAndNonemployeeServicesTransactionQuantityOfSecuritiesIssued
175000 shares
CY2012Q1 pvct Consulting Costs Relates To Warrant Issued
ConsultingCostsRelatesToWarrantIssued
475668
CY2012Q1 pvct Share Based Goods And Nonemployee Services Transaction Quantity Of Warrants Forfeited
ShareBasedGoodsAndNonemployeeServicesTransactionQuantityOfWarrantsForfeited
1500 shares
CY2012Q1 pvct Gain Loss On Revaluation Of Warrants Liability
GainLossOnRevaluationOfWarrantsLiability
148364
CY2012Q1 pvct Share Based Goods And Nonemployee Services Transaction Quantity Of Warrants Issued
ShareBasedGoodsAndNonemployeeServicesTransactionQuantityOfWarrantsIssued
1003000 shares
CY2012Q2 us-gaap Share Based Goods And Nonemployee Services Transaction Quantity Of Securities Issued
ShareBasedGoodsAndNonemployeeServicesTransactionQuantityOfSecuritiesIssued
75000 shares
CY2012Q2 pvct Consulting Costs Relates To Warrant Issued
ConsultingCostsRelatesToWarrantIssued
183908
CY2012Q2 pvct Share Based Goods And Nonemployee Services Transaction Quantity Of Warrants Forfeited
ShareBasedGoodsAndNonemployeeServicesTransactionQuantityOfWarrantsForfeited
4368644 shares
CY2012Q2 pvct Gain Loss On Revaluation Of Warrants Liability
GainLossOnRevaluationOfWarrantsLiability
222546
CY2012Q2 pvct Share Based Goods And Nonemployee Services Transaction Quantity Of Warrants Issued
ShareBasedGoodsAndNonemployeeServicesTransactionQuantityOfWarrantsIssued
454500 shares
CY2013Q2 us-gaap Stock Issued During Period Shares Issued For Cash
StockIssuedDuringPeriodSharesIssuedForCash
3522001 shares
CY2013Q2 us-gaap Share Based Goods And Nonemployee Services Transaction Quantity Of Securities Issued
ShareBasedGoodsAndNonemployeeServicesTransactionQuantityOfSecuritiesIssued
75000 shares
CY2013Q2 pvct Consulting Costs Relates To Warrant Issued
ConsultingCostsRelatesToWarrantIssued
931655
CY2013Q2 pvct Gross Proceeds From Sales Of Common Stock And Warrants
GrossProceedsFromSalesOfCommonStockAndWarrants
2641501
CY2013Q2 pvct Period Of Warrants To Purchase Common Stock
PeriodOfWarrantsToPurchaseCommonStock
P5Y
CY2013Q2 pvct Share Based Goods And Nonemployee Services Transaction Quantity Of Warrants Forfeited
ShareBasedGoodsAndNonemployeeServicesTransactionQuantityOfWarrantsForfeited
1051500 shares
CY2013Q2 pvct Gain Loss On Revaluation Of Warrants Liability
GainLossOnRevaluationOfWarrantsLiability
221149
CY2013Q2 pvct Percentage Of Aggregate Shares Called By Warrant
PercentageOfAggregateSharesCalledByWarrant
0.10 pure
CY2013Q2 pvct Purchase Price Of Common Stock With Warrants
PurchasePriceOfCommonStockWithWarrants
0.75
CY2013Q2 pvct Share Based Goods And Nonemployee Services Transaction Quantity Of Warrants Issued
ShareBasedGoodsAndNonemployeeServicesTransactionQuantityOfWarrantsIssued
2605000 shares
CY2012Q3 us-gaap Share Based Goods And Nonemployee Services Transaction Quantity Of Securities Issued
ShareBasedGoodsAndNonemployeeServicesTransactionQuantityOfSecuritiesIssued
225000 shares
CY2012Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-2390995
CY2012Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
310
CY2012Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-3594338
CY2012Q3 us-gaap Net Income Loss
NetIncomeLoss
-2347111
CY2012Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2296637
CY2012Q3 us-gaap Dividends Preferred Stock
DividendsPreferredStock
43884
CY2012Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1129921
CY2012Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
167780
CY2012Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
0
CY2012Q3 pvct Consulting Costs Relates To Warrant Issued
ConsultingCostsRelatesToWarrantIssued
721753
CY2012Q3 pvct Gain Loss On Change In Fair Value Of Warrant Liability
GainLossOnChangeInFairValueOfWarrantLiability
1246917
CY2012Q3 pvct Share Based Goods And Nonemployee Services Transaction Quantity Of Warrants Forfeited
ShareBasedGoodsAndNonemployeeServicesTransactionQuantityOfWarrantsForfeited
122833 shares
CY2012Q3 pvct Gain Loss On Revaluation Of Warrants Liability
GainLossOnRevaluationOfWarrantsLiability
429818
CY2012Q3 pvct Basic And Diluted Loss Per Common Share
BasicAndDilutedLossPerCommonShare
-0.02
CY2012Q3 pvct Share Based Goods And Nonemployee Services Transaction Quantity Of Warrants Issued
ShareBasedGoodsAndNonemployeeServicesTransactionQuantityOfWarrantsIssued
1732135 shares
CY2012Q3 pvct Weighted Average Number Of Common Shares Outstanding Basic And Diluted
WeightedAverageNumberOfCommonSharesOutstandingBasicAndDiluted
113166988 shares
CY2013Q3 us-gaap Stock Issued During Period Shares Issued For Cash
StockIssuedDuringPeriodSharesIssuedForCash
6150718 shares
CY2013Q3 us-gaap Share Based Goods And Nonemployee Services Transaction Quantity Of Securities Issued
ShareBasedGoodsAndNonemployeeServicesTransactionQuantityOfSecuritiesIssued
75000 shares
CY2013Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
CY2013Q3 us-gaap Gross Profit
GrossProfit
CY2013Q3 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
CY2013Q3 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
CY2013Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-4591385
CY2013Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
293
CY2013Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
CY2013Q3 us-gaap Net Income Loss
NetIncomeLoss
-4552695
CY2013Q3 us-gaap Sales Revenue Net
SalesRevenueNet
CY2013Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2185756
CY2013Q3 us-gaap Dividends Preferred Stock
DividendsPreferredStock
38690
CY2013Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
CY2013Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1296654
CY2013Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
167780
CY2013Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
142310
CY2013Q3 pvct Consulting Costs Relates To Warrant Issued
ConsultingCostsRelatesToWarrantIssued
186223
CY2013Q3 pvct Gross Proceeds From Sales Of Common Stock And Warrants
GrossProceedsFromSalesOfCommonStockAndWarrants
4613037
CY2013Q3 pvct Gain Loss On Change In Fair Value Of Warrant Liability
GainLossOnChangeInFairValueOfWarrantLiability
-902798
CY2013Q3 pvct Period Of Warrants To Purchase Common Stock
PeriodOfWarrantsToPurchaseCommonStock
P5Y
CY2013Q3 pvct Share Based Goods And Nonemployee Services Transaction Quantity Of Warrants Forfeited
ShareBasedGoodsAndNonemployeeServicesTransactionQuantityOfWarrantsForfeited
136500 shares
CY2013Q3 pvct Gain Loss On Revaluation Of Warrants Liability
GainLossOnRevaluationOfWarrantsLiability
337244
CY2013Q3 pvct Percentage Of Aggregate Shares Called By Warrant
PercentageOfAggregateSharesCalledByWarrant
0.10 pure
CY2013Q3 pvct Basic And Diluted Loss Per Common Share
BasicAndDilutedLossPerCommonShare
-0.03
CY2013Q3 pvct Medical Device Revenue
MedicalDeviceRevenue
CY2013Q3 pvct Purchase Price Of Common Stock With Warrants
PurchasePriceOfCommonStockWithWarrants
0.75
CY2013Q3 pvct Share Based Goods And Nonemployee Services Transaction Quantity Of Warrants Issued
ShareBasedGoodsAndNonemployeeServicesTransactionQuantityOfWarrantsIssued
442000 shares
CY2013Q3 pvct Weighted Average Number Of Common Shares Outstanding Basic And Diluted
WeightedAverageNumberOfCommonSharesOutstandingBasicAndDiluted
131573656 shares
pvct Stock Issued During Period For Services Value
StockIssuedDuringPeriodForServicesValue
360000
us-gaap Net Income Loss
NetIncomeLoss
-1316198
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
25000
pvct Stock Issued During Period To Employees Value
StockIssuedDuringPeriodToEmployeesValue
932000

Files In Submission

Name View Source Status
0001193125-13-436620-index-headers.html Edgar Link pending
0001193125-13-436620-index.html Edgar Link pending
0001193125-13-436620.txt Edgar Link pending
0001193125-13-436620-xbrl.zip Edgar Link pending
d612308d10q.htm Edgar Link pending
d612308dex311.htm Edgar Link pending
d612308dex312.htm Edgar Link pending
d612308dex32.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
pvct-20130930.xml Edgar Link completed
pvct-20130930.xsd Edgar Link pending
pvct-20130930_cal.xml Edgar Link unprocessable
pvct-20130930_def.xml Edgar Link unprocessable
pvct-20130930_lab.xml Edgar Link unprocessable
pvct-20130930_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending